Evidence map›Paper›PMID 32401016›Full record

ArticleACS nano2020

Bioresorbable, Miniaturized Porous Silicon Needles on a Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy.

Hyungjun Kim, Heung Soo Lee, Yale Jeon, Woohyun Park, Yue Zhang, Bongjoong Kim, Hanmin Jang, Baoxing Xu, Yoon Yeo, Dong Rip Kim and 1 more

Abstract read
In one paragraph

Article in ACS nano, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Advances in Symbiotic Bioabsorbable Devices.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Flexible Sensing Systems for Cancer Diagnostics.Advances in experimental medicine and biology · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hyungjun KimWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.
Heung Soo LeeSchool of Mechanical Engineering, Hanyang University, Seoul, South Korea.ORCID 0000-0002-9393-0121
Yale JeonSchool of Mechanical Engineering, Hanyang University, Seoul, South Korea.
Woohyun ParkSchool of Mechanical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.
Yue ZhangDepartment of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Bongjoong KimSchool of Mechanical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-9969-6954
Hanmin JangSchool of Mechanical Engineering, Hanyang University, Seoul, South Korea.ORCID 0000-0002-7724-4244
Baoxing XuDepartment of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0000-0002-2591-8737
Yoon YeoDepartment of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0001-9505-7701
Dong Rip KimSchool of Mechanical Engineering, Hanyang University, Seoul, South Korea.ORCID 0000-0001-6398-9483
Chi Hwan LeeWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-4868-7054

Funding

Image-guided radiation-induced permeability (IGRIP) for IGDDR01CA199663 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J., WEICHSELBAUM, RALPH R · 2015 to 2019
$2.5M
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell deathR01CA232419 · NCI · PURDUE UNIVERSITY · PI YEO, YOON · 2018 to 2022
$2.0M
NCI NIH HHS R01 CA199663NCI NIH HHS R01 CA232419
6 · The paper itself

Abstract

Conventional melanoma therapies suffer from the toxicity and side effects of repeated treatments due to the aggressive and recurrent nature of melanoma cells. Less-invasive topical chemotherapies by utilizing polymeric microneedles have emerged as an alternative, but the sustained, long-lasting release of drug cargos remains challenging. In addition, the size of the microneedles is relatively bulky for the small, curvilinear, and exceptionally sensitive cornea for the treatment of ocular melanoma. Here, we report a design of bioresorbable, miniaturized porous-silicon (p-Si) needles with covalently linked drug cargos at doses comparable to those of conventional polymeric microneedles. The p-Si needles are built on a water-soluble film as a temporary flexible holder that can be intimately interfaced with the irregular surface of living tissues, followed by complete dissolution with saline solution within 1 min. Consequently, the p-Si needles remain embedded inside tissues and then undergo gradual degradation, allowing for sustained release of the drug cargos. Its utility in unobtrusive topical delivery of chemotherapy with minimal side effects is demonstrated in a murine melanoma model.

Indexed as

NeedlesSiliconAbsorbable ImplantsAnimalsDrug Delivery SystemsMiceMicroinjectionsPorosityWaterSiliconWaterbioresorbable silicon nanomaterialsmelanoma treatmentminimally invasive injectionsustained drug releasetopical drug delivery

Identifiers

PMID32401016
PMCPMC8279902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.